Jörg Tamihardja

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Radical Prostatectomy

Prostate Cancer

Positron Emission Tomography

Top Venues

Journal of applied clinical medical physics

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Sonja Wegener, Stefan Weick, Robert Schindhelm, Jörg Tamihardja, Otto A Sauer, Gary Razinskas
Feasibility of Ethos adaptive treatments of lung tumors and associated quality assurance. Journal of applied clinical medical physics (2024)
Sonja Wegener, Stefan Weick, Robert Schindhelm, Jörg Tamihardja, Otto A Sauer, Gary Razinskas
Feasibility of Ethos adaptive treatments of lung tumors and associated quality assurance. Journal of applied clinical medical physics 25 (7) (2024)
Sonja Wegener, Stefan Weick, Robert Schindhelm, Jörg Tamihardja, Otto A Sauer, Gary Razinskas
Feasibility of Ethos adaptive treatments of lung tumors and associated quality assurance. Journal of applied clinical medical physics 25 (7) (2024)
Jörg Tamihardja, Leonie Zehner, Philipp E Hartrampf, Sinan Cirsi, Sonja Wegener, Andreas K Buck, Michael Flentje, Bülent Polat
Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era. Cancers 14 (19) (2022)
Jörg Tamihardja, Stefan Weick, Paul Lutyj, Marcus Zimmermann, Klaus Bratengeier, Michael Flentje, Bülent Polat
Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer. Acta oncologica (Stockholm, Sweden) 61 (6) (2022)
Jörg Tamihardja, Leonie Zehner, Philipp E Hartrampf, Dominik Lisowski, Susanne Kneitz, Sinan Cirsi, Gary Razinskas, Michael Flentje, Bülent Polat
Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up. Cancers 14 (15) (2022)
Jörg Tamihardja, Ingulf Lawrenz, Paul Lutyj, Stefan Weick, Matthias Guckenberger, Bülent Polat, Michael Flentje
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 198 (8) (2022)
Jörg Tamihardja, Sinan Cirsi, Patrick Kessler, Gary Razinskas, Florian Exner, Anne Richter, Bülent Polat, Michael Flentje
Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer. Radiation oncology (London, England) 16 (1) (2021)
Jörg Tamihardja, Gary Razinskas, Florian Exner, Anne Richter, Patrick Kessler, Stefan Weick, Johannes Kraft, Frederick Mantel, Michael Flentje, Bülent Polat
Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms. Journal of applied clinical medical physics 22 (9) (2021)
Jörg Tamihardja, Max Schortmann, Ingulf Lawrenz, Stefan Weick, Klaus Bratengeier, Michael Flentje, Matthias Guckenberger, Bülent Polat
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 197 (2) (2020)
Jörg Tamihardja, Maria Zenk, Michael Flentje
MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 195 (2) (2018)